Seres Therapeutics Inc (MCRB) — Net Asset Quality Index
Seres Therapeutics Inc (MCRB) has a Net Asset Quality Index of 30.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $143.47 Million minus total liabilities of $99.78 Million yields net assets of $43.70 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Seres Therapeutics Inc's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Seres Therapeutics Inc Net Asset Quality Index Over Time (2012–2024)
This chart shows how Seres Therapeutics Inc's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 30.5%, representing net assets of $43.70 Million against total assets of $143.47 Million USD. See how liquid is Seres Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Seres Therapeutics Inc (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Seres Therapeutics Inc from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Seres Therapeutics Inc (MCRB) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 9.9% | $13.78 Million | $139.81 Million | $126.03 Million | ▲ +22.4 pp |
| 2023 | -12.5% | $-44.86 Million | $358.60 Million | $403.46 Million | ▼ -15.6 pp |
| 2022 | 3.1% | $10.78 Million | $348.78 Million | $338.00 Million | ▼ -34.0 pp |
| 2021 | 37.1% | $131.51 Million | $354.86 Million | $223.35 Million | ▼ -13.9 pp |
| 2020 | 51.0% | $174.75 Million | $342.94 Million | $168.19 Million | ▲ +87.4 pp |
| 2019 | -36.5% | $-48.32 Million | $132.44 Million | $180.76 Million | ▲ +3.4 pp |
| 2018 | -39.9% | $-48.05 Million | $120.47 Million | $168.52 Million | ▼ -71.9 pp |
| 2017 | 32.0% | $60.70 Million | $189.52 Million | $128.82 Million | ▼ -16.6 pp |
| 2016 | 48.6% | $132.63 Million | $272.65 Million | $140.01 Million | ▼ -46.0 pp |
| 2015 | 94.7% | $205.39 Million | $216.90 Million | $11.51 Million | ▲ +117.5 pp |
| 2014 | -22.8% | $-26.72 Million | $117.34 Million | $144.07 Million | ▼ -52.5 pp |
| 2013 | 29.7% | $631.00K | $2.12 Million | $1.49 Million | ▼ -67.6 pp |
| 2012 | 97.3% | $6.36 Million | $6.54 Million | $178.00K | — |